Achillion Pharmaceuticals Shares Up 84% on Buyout Deal
16 Ottobre 2019 - 2:28PM
Dow Jones News
By Chris Wack
Shares of Achillion Pharmaceuticals (ACHN) jumped 84%, to $6.72,
after Alexion Pharmaceuticals Inc. (ALXN) offered to buy the
company for an initial consideration of $930 million, or $6.30 a
share of Achillion common stock.
The companies said as part of the acquisition, Alexion will also
be acquiring the cash currently on Achillion's balance sheet. As of
Sept. 30, this was about $230 million.
The deal includes the potential for additional consideration in
the form of non-tradeable contingent value rights, which will be
paid to Achillion shareholders if certain clinical and regulatory
milestones are achieved within specified periods. These include
$1.00 a share for the U.S. FDA approval of danicopan and $1.00 a
share for ACH-5228 Phase 3 initiation.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
October 16, 2019 08:13 ET (12:13 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Grafico Azioni Achillion Pharmaceuticals (NASDAQ:ACHN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Achillion Pharmaceuticals (NASDAQ:ACHN)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Achillion Pharmaceuticals Inc (NASDAQ): 0 articoli recenti
Più Achillion Pharmaceuticals Inc Articoli Notizie